{
  "Symbol": "SYK",
  "AssetType": "Common Stock",
  "Name": "Stryker Corporation",
  "Description": "Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.",
  "CIK": "310764",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
  "Address": "2825 AIRVIEW BLVD, KALAMAZOO, MI, US",
  "OfficialSite": "https://www.stryker.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "132255023000",
  "EBITDA": "6006000000",
  "PERatio": "43.65",
  "PEGRatio": "1.934",
  "BookValue": "54.1",
  "DividendPerShare": "3.24",
  "DividendYield": "0.0099",
  "EPS": "7.78",
  "RevenuePerShareTTM": "59.3",
  "ProfitMargin": "0.133",
  "OperatingMarginTTM": "0.256",
  "ReturnOnAssetsTTM": "0.0747",
  "ReturnOnEquityTTM": "0.153",
  "RevenueTTM": "22595000000",
  "GrossProfitTTM": "14545000000",
  "DilutedEPSTTM": "7.78",
  "QuarterlyEarningsGrowthYOY": "-0.526",
  "QuarterlyRevenueGrowthYOY": "0.107",
  "AnalystTargetPrice": "421.86",
  "AnalystRatingStrongBuy": "9",
  "AnalystRatingBuy": "13",
  "AnalystRatingHold": "9",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "1",
  "TrailingPE": "43.65",
  "ForwardPE": "25.06",
  "PriceToSalesRatioTTM": "5.85",
  "PriceToBookRatio": "6.28",
  "EVToRevenue": "6.14",
  "EVToEBITDA": "24.27",
  "Beta": "0.937",
  "52WeekHigh": "405.25",
  "52WeekLow": "312.78",
  "50DayMovingAverage": "372.61",
  "200DayMovingAverage": "364.55",
  "SharesOutstanding": "381689000",
  "DividendDate": "2025-04-30",
  "ExDividendDate": "2025-03-31",
  "Last Updated": "2025-04-23 14:46:04",
  "Price_Day_1": 348.12,
  "Price_Day_2": 339.59,
  "Price_Day_3": 346.5,
  "Price_Day_4": 346.67,
  "Price_Day_5": 346.8,
  "Price_Day_6": 353.42,
  "Price_Day_7": 350.28,
  "Income_totalRevenue_Q1": "6436000000",
  "Income_grossProfit_Q1": "4174000000",
  "Income_netIncome_Q1": "546000000",
  "Income_totalRevenue_Q2": "5494000000",
  "Income_grossProfit_Q2": "3517000000",
  "Income_netIncome_Q2": "834000000",
  "Income_totalRevenue_Q3": "5422000000",
  "Income_grossProfit_Q3": "3324000000",
  "Income_netIncome_Q3": "825000000",
  "Income_totalRevenue_Q4": "5243000000",
  "Income_grossProfit_Q4": "3184000000",
  "Income_netIncome_Q4": "788000000",
  "Balance_totalAssets_Q1": "42971000000",
  "Balance_totalLiabilities_Q1": "22337000000",
  "Balance_totalShareholderEquity_Q1": "20634000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "3652000000",
  "Balance_totalAssets_Q2": "43833000000",
  "Balance_totalLiabilities_Q2": "23684000000",
  "Balance_totalShareholderEquity_Q2": "20149000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "3850000000",
  "Balance_totalAssets_Q3": "39130000000",
  "Balance_totalLiabilities_Q3": "19368000000",
  "Balance_totalShareholderEquity_Q3": "19762000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "1874000000",
  "Balance_totalAssets_Q4": "39402000000",
  "Balance_totalLiabilities_Q4": "20230000000",
  "Balance_totalShareholderEquity_Q4": "19172000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "2330000000",
  "Debt to Equity Ratio": 1.08,
  "Is Complete": true
}